Ipilimumab in the real world: The U.K. expanded access programme (EAP) experience in advanced melanoma.
Saif Ahmad
No relevant relationships to disclose
Wendi Qian
No relevant relationships to disclose
Sarah Gabrielle Ellis
No relevant relationships to disclose
Muhammad Adnan Khattak
No relevant relationships to disclose
Avinash Gupta
No relevant relationships to disclose
Kiruthikah Thillai
No relevant relationships to disclose
Ruth E. Board
Other Remuneration - Bristol-Myers Squibb
Jenny Nobes
Honoraria - Amgen; Roche
Angus Dalgleish
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Other Remuneration - Bristol-Myers Squibb
Simon Aird Grumett
No relevant relationships to disclose
Anthony Maraveyas
Honoraria - Bristol-Myers Squibb
Sarah Danson
Consultant or Advisory Role - Bristol-Myers Squibb
Toby Talbot
No relevant relationships to disclose
Maria Marples
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Other Remuneration - Bristol-Myers Squibb
Ruth Plummer
Consultant or Advisory Role - Bristol-Myers Squibb
Satish Kumar
No relevant relationships to disclose
Mark R. Middleton
Consultant or Advisory Role - AstraZeneca
James M. G. Larkin
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Novartis; Pfizer
Christian Ottensmeier
No relevant relationships to disclose
Philippa Corrie
Consultant or Advisory Role - Bristol-Myers Squibb